Sudden hearing loss from pde-5 inhibitors: A possible cellular stress etiology

Laryngoscope

Volumn 119, Issue 8, 2009, Pages 1586-1589

  Maddox, Patrick T ^a   Saunders, James ^a   Chandrasekhar, Sujana S ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclic guanosine monophosphate; Phosphodiesterase 5 inhibitor; Sudden sensorineural hearing loss

Indexed keywords

DEXAMETHASONE; PHOSPHODIESTERASE V INHIBITOR; PREDNISONE; SILDENAFIL; TADALAFIL;

ADULT; AGED; ARTICLE; AUDIOGRAPHY; CELL STRESS; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ERECTILE DYSFUNCTION; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; NAUSEA; PHYSICIAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SUDDEN DEAFNESS; VERTIGO;

AGE DISTRIBUTION; AGED; AUDIOMETRY; CARBOLINES; COHORT STUDIES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; FOLLOW-UP STUDIES; HEARING LOSS, SUDDEN; HEARING TESTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PIPERAZINES; PURINES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SULFONES;

EID: 68849116084     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20511     Document Type: Article

References (20)

1. Byl F. 76 cases of presumed sudden hearing loss occurring in 1973: Prognosis and incidence. Laryngoscope 1977;87: 817.
2. Wilson W, Byl F, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980;106;772-776.
3. Aronson J. Meyler's Side Effects of Drugs, 15th ed.: The International Encyclopedia of Adverse Drug Reactions and Interactions. New York: Elsevier; 2006:3133.
4. Mukherjee B, Shivakumar T. A case of sensorineural deafness following ingestion of sildenafil. J Laryngol Otol 2007;121:395-397.
5. FDA. FDA Drug Safety Newsletter, vol. 1, no. 2. Winter 2008. Available at: http://www.fda.gov/cder/dsn/2008-winter/postmarketing.htm#pde5.
6. CNN online. Impotence drugs may increase risk for sudden hearing loss. Available at: http://edition.cnn.com/2007/HEALTH/10/18/hearing.loss/. October 18, 2007.
7. IMS Health. 2007 US sales and prescription information. Available at:www.imshealth.com/ims/portal/front/. Accessed March 29, 2008.
8. The Wall Street Journal Online. Viagra is misunderstood despite name recognition. Available at: http://www.usrf. org/breakingnews/bn-111202-viagra/ bn-111202-viagra.html. November 11, 2002.
9. Alderton WK, Cooper CE, Knowles RG. Nitric oxide syn-thases: structure, function and inhibition. Biochem J 2001;357:593-615.
10. Bernier SG, Haldar S, Michel T. Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with endothelial nitric-oxide synthase. J Biol Chem 2000;275:30707-30715.
11. Farzin RA, Spiro DC, Osborne MP, Shelley D, Tarlow MJ. Possible involvement of nitric oxide in the sensorineural hearing loss of bacterial meningitis. Acta Otolaryngol (Stockh) 1997;117:329-336.
12. Heinrich UR, Helling K, Sifferath MC, Brieger J, Huige L, Schmidtmadtmann I. Mann WJ. Gentamicin increases nitric oxide production and induces hearing loss in guinea pigs. Laryngoscope 2008;118;1438-1442.
13. Nakashiima T, Naganawa S, Sone M, Tominaga M, Hayashi H, Yamamoto H, Liu X, Nuttall A. Disorders of cochlear blood flow. Brain Res Rev 2003;43:17-28.
14. Pall Ml.bedeient S.A. "The NO/ONOO" cycle as the etiological mechanism of tinnitus Int Tinnitus J 2007;13:99-104.
15. Popa R, Anniko M, Takumida M. Otoprotectant minimizes hearing defects caused by Pseudomonas aeruginosa Exo- toxin A. Acta Otolaryngol 2000;120:350-358.
16. Balkan E, Balkan S. The effects of nitric oxide synthase inhibitor, L-NAME on NO production during focal cerebral ischemia in rats: could L-NAME be the future treatment of sudden deafness? Intern J Neurosci 1997;89:61-77. (Pubitemid 27204374)
17. Neeb L, Reuter U. Nitric oxide in migraine. CNS Neurol Disord Drug Targets 2007;6:258-264.
18. Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim Biophys Acta 2007;XX:1341-1348.
19. Wei X, Zhao L, Liu J, Dodel RC, Farlow MR, Du Y. Minocycline pervents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience 2005;131:513-521.
20. Merchant SN, Adams JC, Nadol JB. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2005;26:151-160.